Gts Securities LLC Kronos Bio, Inc. Transaction History
Gts Securities LLC
- $2.05 Trillion
- Q4 2024
A detailed history of Gts Securities LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Gts Securities LLC holds 50,000 shares of KRON stock, worth $43,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$43,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRON
# of Institutions
58Shares Held
19.6MCall Options Held
10KPut Options Held
100-
Vida Ventures Advisors, LLC2.77MShares$2.41 Million3.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.67 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.72MShares$1.49 Million0.0% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.25 Million0.1% of portfolio
-
Acadian Asset Management LLC Boston, MA1.3MShares$1.13 Million0.0% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $49.4M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...